Thursday, June 27, 2019

Glenmark Pharma gets USFDA nod for cholesterol lowering drug

Glenmark Pharma gets USFDA nod for cholesterol lowering drug The approval has been granted by the the United States Food and Drug Administration (USFDA) for for Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, the company said in a statement.

from Moneycontrol Business News https://ift.tt/2LxxzZV

No comments:

Post a Comment

Global Market Today: Asian stocks rise after tech-led rebound in US

Asian markets opened higher today. Technology shares led the gains, boosting Wall Street. This rally eased worries about artificial intellig...